NCT03220126View on ClinicalTrials.gov

A Study to Assess the Amount of LY3074828 That Gets Into the Body When Given With LY9999QS, in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

July 17, 2017

Primary Completion Date

February 23, 2018

Study Completion Date

February 23, 2018

Conditions
Healthy
Interventions
BIOLOGICAL

LY3074828

Administered IV

BIOLOGICAL

LY900021

Administered SC

Trial Locations (1)

Unknown

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician., Leeds

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT03220126 - A Study to Assess the Amount of LY3074828 That Gets Into the Body When Given With LY9999QS, in Healthy Participants | Biotech Hunter | Biotech Hunter